Collectively, these discoveries highlight the potential roles of Ptprc and Apoe in the pathogenesis of ARVC and HF, providing new insights into the molecular mechanisms underlying PKP2‐related cardiac dysfunction and fibrosis. Here, PKP2 is linked to arrhythmogenic right ventricular cardiomyopathy.